Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2021
Reporting Period: First Quarter 2021
This filing serves as a notification that the Company issued a press release on May 6, 2021, disclosing its financial results for the first quarter of 2021. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references an attached press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes or comparative financial data are detailed within the text of this specific filing. The document solely announces the availability of the Q1 2021 results in the attached exhibit.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q1 2021 results but does not include the content of that commentary.
Legal Disclaimer: The filing explicitly states that the press release and the information within Item 2.02 are "furnished" and not "filed" for purposes of Section 18 of the Exchange Act. They are not subject to liability under that section nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 6, 2021) for actual Q1 2021 financial figures.
- Verify the specific revenue, net loss, and cash burn rates in the attached press release, as they are absent from this summary text.
- Confirm the status of the Company's liquidity and runway based on the detailed financial statements referenced in the exhibit.
- Note that the information in this 8-K is not deemed "filed" under Section 18 of the Exchange Act.